Instruction for use: Galazolin

Active substance: Xylometazoline

ATX Code R01AA07 Xylometazoline

Pharmacotherapeutic group:

Alpha-adrainomimetiki

decongestant

The nosological classification (ICD-10)

H65 purulent otitis media

Inflammation of the middle ear, Allergic otitis media

J00 Acute nasopharyngitis [runny nose]

Viral rhinitis, Inflammation of the nasopharynx, Inflammatory diseases of the nose, purulent rhinitis, Nasal congestion, Nasal congestion with colds and flu, The difficulty of nasal breathing, The difficulty of nasal breathing for colds, Difficulty in nasal breathing, Difficulty in nasal breathing in colds, nasal, hypersecretion, cold, ARI with rhinitis phenomena, coryza, Acute rhinitis of various origins, Acute rhinitis with thick purulent mucous exudate, Acute nasopharyngitis, Swelling of the mucosa of the nasopharynx, Rhinitis, rhinorrhea, Infectious-inflammatory diseases of ENT organs, heavy cold, rhinopharyngitis, nasopharyngitis

J01 Acute sinusitis

Inflammation of the sinuses, Inflammatory diseases of the paranasal sinuses, Purulent inflammation of the paranasal sinuses, Infectious-inflammatory diseases of ENT organs, Infection of the sinuses, Combined sinusitis, Exacerbation of sinusitis, Acute inflammation of the paranasal sinuses, Acute bacterial sinusitis, Acute sinusitis in adults, Subacute sinusitis, acute Sinusitis, sinusitis

J30 Vasomotor and allergic rhinitis

Allergic rinopatiya, Allergic rhinosinusopathy, Allergic respiratory diseases, Allergic rhinitis, nasal allergy, Seasonal Allergic Rhinitis, Vasomotor rhinitis, Long-allergic rhinitis, Perennial allergic rhinitis, Perennial allergic rhinitis, Year-round or seasonal allergic rhinitis, Year-round allergic rhinitis nature, Rhinitis allergic vasomotor, Exacerbation of pollen allergy in the form of Syndrome rinokonyunktivalnogo, Acute allergic rhinitis, Edema of the nasal mucosa, Edema of the nasal mucosa, Swelling of the mucosa of the nasal cavity, Swelling of the nasal mucosa, Swelling of the nasal mucosa, pollen disease, Permanent allergic rhinitis, rhinoconjunctivitis, rhinosinusitis,rhinosinusopathy, Seasonal allergic rhinitis, Seasonal Allergic Rhinitis, Haymarket rhinitis, Chronic allergic rhinitis, Allergic respiratory diseases

J32 Chronic sinusitis

Allergic rhinosinusopathy, purulent sinusitis, Catarrh nasopharyngeal area, Catarrh of the sinuses, Exacerbation of sinusitis, chronic Sinusitis

Composition

Nasal Gel 0.05% 1 g

Xylometazoline hydrochloride 500 mcg

Patients with dispenser 10 g; in box 1 bottle.

Nasal Gel 0.1% 1 g

Xylometazoline hydrochloride 1 mg

Patients with dispenser 10 g; in box 1 bottle.

Nasal drops 0.05 ml of 1%

Xylometazoline hydrochloride 500 mcg

in bottles of 10 ml; in box 1 bottle.

Nasal drops 1 ml of 0.1%

Xylometazoline hydrochloride 1 mg

in bottles of 10 ml; in box 1 bottle.

Pharmachologic effect
vasoconstrictor, antikongestivnoe, alpha adrenomimeticheskoe.

Narrowing of blood vessels of the nasal mucosa, reduces congestion, edema, and the amount of discharge.

pharmacodynamics

The action comes after 5-10 minutes and lasts for 5-6 hours (vasoconstriction lasts 8-12 hours).

Indications

Acute rhinitis (viral, bacterial, allergic), acute or chronic sinusitis, acute otitis media

Contraindications

Hypersensitivity, atrophic rhinitis, increased intraocular pressure, angle-closure glaucoma, hypertension, marked atherosclerosis, tachycardia, hyperthyroidism, diabetes, pheochromocytoma, simultaneous reception of MAO inhibitors and the period up to 14 days after the end of their application.

Pregnancy and breast-feeding

Perhaps, but only after a careful assessment of risks and benefits to mother and fetus.

Side effects of Galazolin

Dryness of the nasal mucosa, sneezing, feeling of "fullness" of the nose (reactive hyperemia), very rarely - headache, anxiety, insomnia, fatigue, nausea, tachycardia, and increased blood pressure (an overdose).

Interaction

Incompatible with MAO inhibitors and tricyclic antidepressants.

Galazolin Dosage and Administration

Intranasal.

Nasal drops 0.1%. Adults and children over 6 years: usually 2-3 drops of the solution to both nasal passage 2-3 times a day or 1 drop of gel 3 times a day.

Nasal drops 0.05%. Children aged 2 to 6 years of age: 1-2 drops of the solution into both nasal running 1-2 times per day.

The course - usually 3-5 days (up to 2 weeks).

Nasal gel.

Before using the product, remove the attachment, then tap dispenser 3-5 times before the onset of the drug haze.

Gel 1 0.05% dose nasal spray device with a metering contains 0.05 mg Xylometazoline. Children aged 3-6 years, the average dose is 1 spray in each nostril 1-2 times a day; 6-12 years - 1-2 spray in each nostril 2-3 times a day.

Gel 1 0.1% dose nasal spray using a metering device contains 0.1 mg Xylometazoline. Adults and children over 12 years, the average dose is 1 spray in each nostril 2-3 times a day.

Formulation should not be used more than three times a day. The duration of the drug - no more than 3-5 days (maximum - up to 2 weeks.

Overdose

Symptoms (in children), rarely - increased heart rate, arrhythmia, increased blood pressure, sometimes - confusion.

Treatment: symptomatic.

Precautionary measures

Be wary of during the drivers of vehicles and people skills relate to the high concentration of attention.

special instructions

Avoid long-term use and overdose (weakening of the action and likelihood of mucosal atrophy and reactive hyperemia with drug rhinitis).

Storage conditions of Galazolin

In a dry, dark place, at a temperature of 15-25 ° C.

Keep out of the reach of children.
Shelf life of Galazolin

nasal gel 0.05% - 3 years.

nasal gel 0.1% - 3 years.

nasal drops 0.05% - 4 years.

nasal drops 0.1% - 4 years.

Do not use beyond the expiration date printed on the package.